X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (31950) 31950
Book Chapter (85) 85
Magazine Article (35) 35
Dissertation (34) 34
Conference Proceeding (23) 23
Newsletter (8) 8
Publication (7) 7
Newspaper Article (5) 5
Book / eBook (4) 4
Book Review (1) 1
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (26050) 26050
science & technology (19551) 19551
life sciences & biomedicine (17225) 17225
female (16728) 16728
doxorubicin - administration & dosage (15730) 15730
antineoplastic combined chemotherapy protocols - therapeutic use (14997) 14997
male (13060) 13060
middle aged (11448) 11448
doxorubicin - therapeutic use (10398) 10398
adult (9811) 9811
oncology (9085) 9085
aged (8770) 8770
doxorubicin (7930) 7930
cyclophosphamide - administration & dosage (7109) 7109
animals (6817) 6817
chemotherapy (5936) 5936
vincristine - administration & dosage (5656) 5656
cancer (5162) 5162
treatment outcome (4643) 4643
combined modality therapy (4215) 4215
doxorubicin - adverse effects (4161) 4161
mice (3949) 3949
doxorubicin - pharmacology (3832) 3832
anthracyclines (3700) 3700
cyclophosphamide - therapeutic use (3540) 3540
breast neoplasms - drug therapy (3518) 3518
antineoplastic combined chemotherapy protocols - adverse effects (3427) 3427
cisplatin - administration & dosage (3338) 3338
prognosis (3315) 3315
prednisone - administration & dosage (3289) 3289
antineoplastic combined chemotherapy protocols - administration & dosage (3285) 3285
cell line, tumor (3214) 3214
adolescent (3195) 3195
vincristine - therapeutic use (3195) 3195
antineoplastic agents - therapeutic use (3041) 3041
pharmacology & pharmacy (2970) 2970
hematology (2616) 2616
neoplasm staging (2521) 2521
breast cancer (2381) 2381
abridged index medicus (2330) 2330
methotrexate - administration & dosage (2326) 2326
drug delivery systems (2201) 2201
survival rate (2185) 2185
prednisone - therapeutic use (2176) 2176
aged, 80 and over (2096) 2096
retrospective studies (2096) 2096
remission induction (2094) 2094
follow-up studies (2063) 2063
tumors (2053) 2053
drug administration schedule (2045) 2045
disease-free survival (2016) 2016
apoptosis (1966) 1966
care and treatment (1930) 1930
etoposide - administration & dosage (1902) 1902
science & technology - other topics (1829) 1829
survival analysis (1807) 1807
fluorouracil - administration & dosage (1798) 1798
doxorubicin - analogs & derivatives (1797) 1797
time factors (1796) 1796
breast neoplasms - pathology (1787) 1787
child (1784) 1784
antibiotics, antineoplastic - therapeutic use (1734) 1734
drugs (1705) 1705
bleomycin - administration & dosage (1704) 1704
analysis (1676) 1676
antibiotics, antineoplastic - administration & dosage (1626) 1626
physical sciences (1620) 1620
dose-response relationship, drug (1560) 1560
antineoplastic agents - pharmacology (1551) 1551
lymphoma, large b-cell, diffuse - drug therapy (1543) 1543
antineoplastic agents - administration & dosage (1520) 1520
research (1516) 1516
cancer therapies (1509) 1509
chemistry (1496) 1496
drug therapy, combination (1493) 1493
chemotherapy, adjuvant (1477) 1477
neoplasms - drug therapy (1473) 1473
technology (1466) 1466
rats (1456) 1456
drug resistance (1455) 1455
lung neoplasms - drug therapy (1450) 1450
doxorubicin - chemistry (1414) 1414
lymphoma, non-hodgkin - drug therapy (1412) 1412
apoptosis - drug effects (1396) 1396
medicine & public health (1396) 1396
health aspects (1374) 1374
materials science (1353) 1353
cyclophosphamide - adverse effects (1350) 1350
prospective studies (1342) 1342
cell survival - drug effects (1341) 1341
doxorubicin - pharmacokinetics (1340) 1340
nanoparticles (1329) 1329
rituximab (1326) 1326
vinblastine - administration & dosage (1292) 1292
mice, nude (1266) 1266
clinical trials as topic (1248) 1248
toxicity (1242) 1242
drug therapy (1239) 1239
lymphomas (1230) 1230
doxorubicin - toxicity (1155) 1155
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (29275) 29275
Japanese (1857) 1857
German (526) 526
French (414) 414
Chinese (404) 404
Spanish (259) 259
Russian (243) 243
Italian (152) 152
Polish (123) 123
Hungarian (38) 38
Portuguese (37) 37
Czech (21) 21
Dutch (18) 18
Ukrainian (16) 16
Hebrew (13) 13
Serbian (10) 10
Korean (9) 9
Croatian (8) 8
Bulgarian (6) 6
Lithuanian (6) 6
Finnish (4) 4
Norwegian (4) 4
Swedish (4) 4
Romanian (3) 3
Turkish (3) 3
Arabic (1) 1
Danish (1) 1
Persian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer Treatment Reviews, ISSN 0305-7372, 2014, Volume 40, Issue 9, pp. 1080 - 1088
Highlights • PTCL has a poor prognosis; existing therapies are insufficient. • We summarize current evidence on novel therapies for relapsed/refractory PTCL. •... 
Hematology, Oncology and Palliative Medicine | Antifolate | Nucleoside analog | Histone deacetylase inhibitor | Fusion protein | Peripheral T-cell lymphoma | Immunomodulatory agent | Life Sciences & Biomedicine | Oncology | Science & Technology | Doxorubicin - therapeutic use | Humans | Recombinant Fusion Proteins - therapeutic use | Interleukin-2 - therapeutic use | Neoplasm Recurrence, Local - drug therapy | Antineoplastic Agents - therapeutic use | Cyclophosphamide - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Folic Acid Antagonists - therapeutic use | Stem Cell Transplantation | Topoisomerase Inhibitors - pharmacology | Thalidomide - analogs & derivatives | Diphtheria Toxin - therapeutic use | Topoisomerase Inhibitors - therapeutic use | Immunoconjugates - therapeutic use | Antineoplastic Agents - pharmacology | Depsipeptides - therapeutic use | Prednisolone - therapeutic use | Lymphoma, T-Cell, Peripheral - drug therapy | Antibodies, Monoclonal, Humanized - therapeutic use | Alemtuzumab | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Lymphoma, T-Cell, Peripheral - pathology | Vincristine - therapeutic use | Histone Deacetylase Inhibitors - therapeutic use | Lymphoma, T-Cell, Peripheral - therapy | Thalidomide - therapeutic use | Folic Acid Antagonists - pharmacology | Care and treatment | Lymphomas | T cells | Health aspects | Index Medicus
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 07/2017, Volume 35, Issue 20, pp. 2260 - 2267
Journal Article
Paediatric drugs, ISSN 1174-5878, 2010, Volume 12, Issue 2, pp. 85 - 98
Hodgkin lymphoma is one of the few cancers that affect both adults and children. Cure rates for Hodgkin lymphoma remain among the best for pediatric cancers.... 
Anthracyclines, therapeutic use | Chlormethine, therapeutic use | Alkylating-agents, therapeutic use | Brentuximab-vedotin, therapeutic use | Cisplatin, therapeutic use | Bortezomib, therapeutic use | Bleomycin, therapeutic use | Children | Index Medicus
Journal Article
The New England journal of medicine, ISSN 1533-4406, 07/2011, Volume 365, Issue 3, pp. 203 - 212
BEACOPP combination chemotherapy was compared with ABVD chemotherapy in advanced Hodgkin's disease. BEACOPP therapy was associated with higher initial rates of... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Doxorubicin - therapeutic use | Dacarbazine - adverse effects | Dacarbazine - therapeutic use | Humans | Middle Aged | Salvage Therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Vinblastine - therapeutic use | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Young Adult | Hodgkin Disease - radiotherapy | Bleomycin - therapeutic use | Vinblastine - adverse effects | Hodgkin Disease - drug therapy | Hodgkin Disease - mortality | Adult | Female | Etoposide - adverse effects | Prednisone - adverse effects | Kaplan-Meier Estimate | Proportional Hazards Models | Hematopoietic Stem Cell Transplantation | Etoposide - therapeutic use | Combined Modality Therapy | Bleomycin - adverse effects | Remission Induction | Disease-Free Survival | Procarbazine - adverse effects | Procarbazine - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Hodgkin Disease - therapy | Adolescent | Vincristine - therapeutic use | Vincristine - adverse effects | Neoplasm Staging | Doxorubicin - adverse effects | Prednisone - therapeutic use | Procarbazine | Vinblastine | Disease | Etoposide | Prednisone | Family medical history | Radiation therapy | Patients | Lymphoma | Doxorubicin | Survival | Vincristine | Studies | Hepatitis | Dacarbazine | Cyclophosphamide | Chemotherapy | Bleomycin | Tomography | Lymphomas | Hodgkin's disease | Index Medicus | Abridged Index Medicus
Journal Article
British journal of haematology, ISSN 0007-1048, 06/2015, Volume 169, Issue 5, pp. 672 - 682
Summary This multicentre, randomized, phase II study was conducted to examine whether the addition of mogamulizumab, a humanized anti‐CC chemokine receptor 4... 
mogamulizumab | randomized phase II study | CCR4 | adult T‐cell leukaemia‐lymphoma | antibody therapy | Adult T-cell leukaemia-lymphoma | Mogamulizumab | Antibody therapy | Randomized phase II study | Life Sciences & Biomedicine | Hematology | Science & Technology | Doxorubicin - therapeutic use | Nitrosourea Compounds - adverse effects | Prednisolone - adverse effects | Nitrosourea Compounds - therapeutic use | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Carboplatin - adverse effects | Antibodies, Monoclonal, Humanized - administration & dosage | Leukemia-Lymphoma, Adult T-Cell - drug therapy | Carboplatin - therapeutic use | Vindesine - adverse effects | Vindesine - therapeutic use | Aged, 80 and over | Adult | Female | Prednisolone - therapeutic use | Etoposide - adverse effects | Leukemia-Lymphoma, Adult T-Cell - mortality | Etoposide - therapeutic use | Treatment Outcome | Leukemia-Lymphoma, Adult T-Cell - pathology | Disease Progression | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Vincristine - therapeutic use | Vincristine - adverse effects | Aged | Doxorubicin - adverse effects | Chemotherapy | Lymphomas | T cells | Leukemia | Cancer | Index Medicus | Haematological Malignancy | Research Paper
Journal Article
Biomaterials, ISSN 0142-9612, 07/2015, Volume 57, pp. 93 - 106
Journal Article
Journal Article
The Lancet (British edition), ISSN 0140-6736, 05/2012, Volume 379, Issue 9828, pp. 1791 - 1799
Summary Background The intensity of chemotherapy and need for additional radiotherapy in patients with advanced stage Hodgkin's lymphoma has been unclear. We... 
Internal Medicine | Radiotherapy Dosage | Doxorubicin/adverse effects | Etoposide/adverse effects | Procarbazine/adverse effects | Prospective Studies | Hodgkin Disease/drug therapy | Humans | Middle Aged | Proportional Hazards Models | Male | Treatment Outcome | Positron-Emission Tomography | Antineoplastic Combined Chemotherapy Protocols/adverse effects | Prednisone/adverse effects | Treatment Failure | Adolescent | Survival Analysis | Adult | Female | Cyclophosphamide/adverse effects | Vincristine/adverse effects | Neoplasm Staging | Bleomycin/adverse effects | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Doxorubicin - therapeutic use | Hodgkin Disease - pathology | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Hodgkin Disease - radiotherapy | Bleomycin - therapeutic use | Hodgkin Disease - drug therapy | Etoposide - adverse effects | Prednisone - adverse effects | Etoposide - therapeutic use | Bleomycin - adverse effects | Procarbazine - adverse effects | Procarbazine - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Vincristine - therapeutic use | Vincristine - adverse effects | Doxorubicin - adverse effects | Prednisone - therapeutic use | Chemotherapy | Usage | Care and treatment | PET imaging | Diagnosis | Hodgkin's disease | Cancer | Medical imaging | Meetings | Patient safety | Oncology | Lymphomas | Histology | Radiation therapy | Ovarian cancer | Index Medicus | Abridged Index Medicus
Journal Article